education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Iklan
Iklan
MIMS home
Drugs
Info
Sedafol
Sedafol
propofol
Manufacturer:
Darya-Varia
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Full Prescribing Info
Contents
Indications/Uses
Dosage/Direction for Use
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Bahasa Concise Prescribing Info
Full Prescribing Info
Contents
Indications/Uses
Dosage/Direction for Use
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Contents
Propofol
Indications/Uses
Induction & maintenance of anesth in adults & childn ≥3 yr. Continuous sedation & control stress responses to intubated & mechanically ventilated adult patients in ICU.
Click to view Sedafol detailed prescribing information
Dosage/Direction for Use
General anesth
Titrate approx 40 mg every 10 sec.
Patient <55 yr
2-2.5 mg/kg.
Elderly or ASA Grade III/IV patient
Dose may be reduced to 1 mg/kg, slower administration rate of approx 2 mL every 10 sec.
Click to view Sedafol detailed prescribing information
MIMS Class
Anaesthetics - Local & General
ATC Classification
N01AX10 - propofol ; Belongs to the class of other general anesthetics.
Regulatory Classification
K
Presentation/Packing
Form
Sedafol emulsion for inj/infusion 10 mg/mL
Packing/Price
20 mL x 10 × 1's
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Daftar Gratis untuk Melanjutkan Membaca
Lanjutkan dengan Google
Daftar dengan Email
Sudah menjadi anggota?
Masuk
Daftar Gratis untuk Melanjutkan Membaca
Lanjutkan dengan Google
Daftar dengan Email
Sudah menjadi anggota?
Masuk